Market Research

Antibody Production Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Software), By Process  (Upstream Processing, Downstream Processing), By Type (Monoclonal Antibody, Polyclonal Antibody), By End-Use (Pharmaceutical

Best Price Guarantee Publisher Published Date SKU
from $3,500 Straits Research November, 2024 STRA19656389
Best Price Guarantee
Price from $3,500
Publisher Straits Research
Published Date November, 2024
SKU STRA19656389

Antibody Production Market Analysis and Insights

The Antibody Production Market size is anticipated to reach USD 16.8 billion in 2023 and it is projected to reach USD 54.4 billion by 2032, growing at a CAGR of 12.5% during the forecast period.

The Global Antibody Production Market Analysis report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis.

The Global Antibody Production Market growth, Size report provides a comprehensive analysis of the Biotechnology industry, analyzes and identifies changes in market conditions set to impact future business decisions by analyzing.

Research Methodology

Our research methodology constitutes a mix of secondary & primary research which ideally starts from exhaustive data mining, conducting primary interviews (suppliers/distributors/end-users), and formulating insights, estimates, growth rates accordingly. Final primary validation is a mandate to confirm our research findings with Key Opinion Leaders (KoLs), Industry Experts, Antibody Production Market includes major supplies & Independent Consultants among others.

Global Market Scope and Antibody Production Market

The scope of the report is to provide a 360-degree view of the market outlook by assessing the entire value chain and analyzing the key Antibody Production Market trends from 2024 to 2032 underlying in specific geographies. Qualitative and quantitative aspects are interlinked to provide rationales on market numbers, CAGR, and forecasts.

Antibody Production Market Country Level Analysis

The Global Antibody Production Market Industry Analysis Research Report provides a basic overview of industry dominating market share expected 2024 to 2032. A detailed section on Antibody Production Market share and status of critical industries is included in the report, covering. Market Segment by Regions (North America, Europe, Asia Pacific, South America and The Middle East and Africa), coverage with region wise data from 2024 to 2032.

Top Players in Antibody Production Market

Some of the other major highlights of the demand for Antibody Production Market include analysis, purchasing volume, prices, pricing analysis, and regulatory framework. Coverage on manufacturing structure, distribution channels, and Porter’s Five Forces analysis are also incorporated in the scope to provide analysis on the demand and supply side. This is anticipated to create opportunities for the growth of the Antibody Production Market during the forecast period.

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Pacific Biosciences of California, Inc.
  • BGI
  • QIAGEN
  • Agilent Technologies
  • PerkinElmer, Inc.
  • ProPhase Labs, Inc. (Nebula Genomics)
  • Psomagen
  • Azenta US, Inc.

Market Segmentation

The Global Antibody Production Market Share, Demand provides the most up-to-date Biotechnology industry data on the actual market situation, size, trends and future outlook. The research includes historic data from 2021 to 2023 and forecasts until 2032.
  • By Product
    • Instruments
      • Bioreactors
      • Multi-use Bioreactors
      • Single-use Bioreactors
      • Chromatography Systems
      • Filtration systems
    • Consumables
      • Media
      • Reagent
      • Buffers and Reagents
      • Chromatography Resins and Columns
      • Filtration Consumables and Accessories
      • Others
    • Software
  • By Process 
    • Upstream Processing
    • Downstream Processing
  • By Type
    • Monoclonal Antibody
    • Polyclonal Antibody
  • By End-Use
    • Pharmaceutical and Biotechnology Companies
    • Research Laboratories
    • CROs and CDMOs

Regions Coverd
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Nordic
    • Benelux
    • Rest of Europe
  • APAC
    • China
    • Korea
    • Japan
    • India
    • Australia
    • Singapore
    • Taiwan
    • South East Asia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • UAE
    • Turkey
    • Saudi Arabia
    • South Africa
    • Egypt
    • Nigeria
    • Rest of MEA
  • LATAM
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Colombia
    • Rest of LATAM

Reasons for Doing the Study:

This report is an update of an earlier (2023) Research study. Since the previous edition of this report was published, the Public Safety and Security market has continued to evolve. In particular, the overall market growth rates forecast in the previous edition now appear to have been too high, extending the time-line for the market’s development. In order to give its readers, the most up-to-date and accurate assessment of future market opportunities.


1 Executive Summary
2 Research Scope & Segmentation
2.1 Research Objectives
2.2 Limitations & Assumptions
2.3 Market Scope & Segmentation
2.4 Currency & Pricing Considered
3 Market Opportunity Assessment
3.1 Emerging Regions / Countries
3.2 Emerging Companies
3.3 Emerging Applications / End Use
4 Market Trends
4.1 Drivers
4.2 Market Warning Factors
4.3 Latest Macro Economic Indicators
4.4 Geopolitical Impact
4.5 Technology Factors
5 Market Assessment
5.1 Porters Five Forces Analysis
5.2 Value Chain Analysis
6 Global Antibody Production Market Size Analysis
6.1 By Product
6.1.1 Instruments
6.1.1.1 Bioreactors
6.1.1.2 Multi-use Bioreactors
6.1.1.3 Single-use Bioreactors
6.1.1.4 Chromatography Systems
6.1.1.5 Filtration systems
6.1.2 Consumables
6.1.2.1 Media
6.1.2.2 Reagent
6.1.2.3 Buffers and Reagents
6.1.2.4 Chromatography Resins and Columns
6.1.2.5 Filtration Consumables and Accessories
6.1.2.6 Others
6.1.3 Software
6.2 By Process 
6.2.1 Upstream Processing
6.2.2 Downstream Processing
6.3 By Type
6.3.1 Monoclonal Antibody
6.3.2 Polyclonal Antibody
6.4 By End-Use
6.4.1 Pharmaceutical and Biotechnology Companies
6.4.2 Research Laboratories
6.4.3 CROs and CDMOs
7 North America Market Analysis
7.1 By Product
7.1.1 Instruments
7.1.1.1 Bioreactors
7.1.1.2 Multi-use Bioreactors
7.1.1.3 Single-use Bioreactors
7.1.1.4 Chromatography Systems
7.1.1.5 Filtration systems
7.1.2 Consumables
7.1.2.1 Media
7.1.2.2 Reagent
7.1.2.3 Buffers and Reagents
7.1.2.4 Chromatography Resins and Columns
7.1.2.5 Filtration Consumables and Accessories
7.1.2.6 Others
7.1.3 Software
7.2 By Process 
7.2.1 Upstream Processing
7.2.2 Downstream Processing
7.3 By Type
7.3.1 Monoclonal Antibody
7.3.2 Polyclonal Antibody
7.4 By End-Use
7.4.1 Pharmaceutical and Biotechnology Companies
7.4.2 Research Laboratories
7.4.3 CROs and CDMOs
7.4 U.S.
7.5 Canada
8 Europe Market Analysis
8.1 By Product
8.1.1 Instruments
8.1.1.1 Bioreactors
8.1.1.2 Multi-use Bioreactors
8.1.1.3 Single-use Bioreactors
8.1.1.4 Chromatography Systems
8.1.1.5 Filtration systems
8.1.2 Consumables
8.1.2.1 Media
8.1.2.2 Reagent
8.1.2.3 Buffers and Reagents
8.1.2.4 Chromatography Resins and Columns
8.1.2.5 Filtration Consumables and Accessories
8.1.2.6 Others
8.1.3 Software
8.2 By Process 
8.2.1 Upstream Processing
8.2.2 Downstream Processing
8.3 By Type
8.3.1 Monoclonal Antibody
8.3.2 Polyclonal Antibody
8.4 By End-Use
8.4.1 Pharmaceutical and Biotechnology Companies
8.4.2 Research Laboratories
8.4.3 CROs and CDMOs
8.4 U.K.
8.5 Germany
8.6 France
8.7 Spain
8.8 Italy
8.9 Russia
8.10 Nordic
8.11 Benelux
8.12 Rest of Europe
9 APAC Market Analysis
9.1 By Product
9.1.1 Instruments
9.1.1.1 Bioreactors
9.1.1.2 Multi-use Bioreactors
9.1.1.3 Single-use Bioreactors
9.1.1.4 Chromatography Systems
9.1.1.5 Filtration systems
9.1.2 Consumables
9.1.2.1 Media
9.1.2.2 Reagent
9.1.2.3 Buffers and Reagents
9.1.2.4 Chromatography Resins and Columns
9.1.2.5 Filtration Consumables and Accessories
9.1.2.6 Others
9.1.3 Software
9.2 By Process 
9.2.1 Upstream Processing
9.2.2 Downstream Processing
9.3 By Type
9.3.1 Monoclonal Antibody
9.3.2 Polyclonal Antibody
9.4 By End-Use
9.4.1 Pharmaceutical and Biotechnology Companies
9.4.2 Research Laboratories
9.4.3 CROs and CDMOs
9.4 China
9.5 Korea
9.6 Japan
9.7 India
9.8 Australia
9.9 Singapore
9.10 Taiwan
9.11 South East Asia
9.12 Rest of Asia-Pacific
10 Middle East and Africa Market Analysis
10.1 By Product
10.1.1 Instruments
10.1.1.1 Bioreactors
10.1.1.2 Multi-use Bioreactors
10.1.1.3 Single-use Bioreactors
10.1.1.4 Chromatography Systems
10.1.1.5 Filtration systems
10.1.2 Consumables
10.1.2.1 Media
10.1.2.2 Reagent
10.1.2.3 Buffers and Reagents
10.1.2.4 Chromatography Resins and Columns
10.1.2.5 Filtration Consumables and Accessories
10.1.2.6 Others
10.1.3 Software
10.2 By Process 
10.2.1 Upstream Processing
10.2.2 Downstream Processing
10.3 By Type
10.3.1 Monoclonal Antibody
10.3.2 Polyclonal Antibody
10.4 By End-Use
10.4.1 Pharmaceutical and Biotechnology Companies
10.4.2 Research Laboratories
10.4.3 CROs and CDMOs
10.4 UAE
10.5 Turkey
10.6 Saudi Arabia
10.7 South Africa
10.8 Egypt
10.9 Nigeria
10.10 Rest of MEA
11 LATAM Market Analysis
11.1 By Product
11.1.1 Instruments
11.1.1.1 Bioreactors
11.1.1.2 Multi-use Bioreactors
11.1.1.3 Single-use Bioreactors
11.1.1.4 Chromatography Systems
11.1.1.5 Filtration systems
11.1.2 Consumables
11.1.2.1 Media
11.1.2.2 Reagent
11.1.2.3 Buffers and Reagents
11.1.2.4 Chromatography Resins and Columns
11.1.2.5 Filtration Consumables and Accessories
11.1.2.6 Others
11.1.3 Software
11.2 By Process 
11.2.1 Upstream Processing
11.2.2 Downstream Processing
11.3 By Type
11.3.1 Monoclonal Antibody
11.3.2 Polyclonal Antibody
11.4 By End-Use
11.4.1 Pharmaceutical and Biotechnology Companies
11.4.2 Research Laboratories
11.4.3 CROs and CDMOs
11.4 Brazil
11.5 Mexico
11.6 Argentina
11.7 Chile
11.8 Colombia
11.9 Rest of LATAM
12 Competitive Landscape
12.1 Global Antibody Production Market Share By Players
12.2 M & A Agreements & Collaboration Analysis
13 Market Players Assessment
13.1 American International Industries (GIGI)
13.1.1 Overview
13.1.2 Business Information
13.1.3 Revenue
13.1.4 ASP
13.1.5 Swot Analysis
13.1.6 Recent Developments
13.2 Thermo Fisher Scientific, Inc.
13.3 Pacific Biosciences of California, Inc.
13.4 BGI
13.5 QIAGEN
13.6 Agilent Technologies
13.7 PerkinElmer, Inc.
13.8 ProPhase Labs, Inc. (Nebula Genomics)
13.9 Psomagen
13.10 Azenta US, Inc.
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.1.1 Major secondary sources
14.1.1.2 Key data from secondary sources
14.1.2 Primary Data
14.1.2.1 Key data from primary sources
14.1.2.2 Breakdown of primaries
14.1.3 Secondary And Primary Research
14.1.3.1 Key industry insights
14.2 Market Size Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach
14.2.3 Market Projection
14.3 Research Assumptions
14.3.1 Assumptions
14.4 Limitations
14.5 Risk Assessment
15 Appendix
15.1 Discussion Guide
15.2 Customization Options
15.3 Related Reports
16 Disclaimer

$3,500
$4,500

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings